Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease
Authors:
Open Access
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 28 (8) , 940-947
Abstract
Background/aim: The frequency of sarcopenia, defined as loss of both muscle volume and strength, was analyzed in chronic liver disease (CLD). Methods and materials: From April to September 2015, 807 Japanese CLD patients treated as outpatients were enrolled (67.1±10.0 years, men : women=466 : 341, hepatitis C virus : hepatitis B virus : hepatitis B and C virus : alcohol : other=511 : 134 : 3 : 45 : 114). Sarcopenia was diagnosed when the patient showed muscle volume loss and reduced handgrip strength, whereas those with only muscle volume loss were classified as ‘v-presarcopenia’ and those with only reduced handgrip strength were classified as ‘s-presarcopenia’. Muscle volume loss was determined using computed tomography findings and a previously reported index (psoas index), and cut-off values for reduced handgrip strength presented by the Asia Working Group for Sarcopenia (AWGS) (AWGS/grip criteria) and European Working Group on Sarcopenia in Older People (EWGSOP) (EWGSOP/grip criteria) (men; 26 and 30 kg, women; 18 and 20 kg, respectively) were used. Clinical features were analyzed for diagnoses of chronic hepatitis (CH, n=381), liver cirrhosis Child-Pugh A (n=330), and liver cirrhosis Child-Pugh B/C (n=96). Results: When the AWGS/grip criteria were used, the frequencies of sarcopenia, v-presarcopenia, and s-presarcopenia in CH were 3.9, 7.9, and 19.4%, whereas those in Child-Pugh A were 4.8, 17.6, and 21.8% and those in Child-Pugh B/C were 16.7, 11.5, and 39.6%, respectively. When the EWGSOP/grip criteria were used, these frequencies were 7.1, 4.7, and 33.1%, in CH, 11.8, 10.6, and 32.7%, in Child-Pugh A, and 21.9, 6.3, and 49.0%, in Child-Pugh B/C, respectively. The incidence rates of sarcopenia and both types of presarcopenia increased with progression of CLD. Conclusion: Evaluation of handgrip strength and psoas index is an easy and effective method for the detection of sarcopenia and presarcopenia.Keywords
This publication has 25 references indexed in Scilit:
- Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluationJournal of Gastroenterology, 2015
- Impact of muscle wasting on survival in patients with liver cirrhosisWorld Journal of Gastroenterology, 2015
- Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomographyJournal of Hepatology, 2014
- Sarcopenia in Asia: Consensus Report of the Asian Working Group for SarcopeniaJournal of the American Medical Directors Association, 2014
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinomaBritish Journal of Surgery, 2013
- Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver TransplantationAmerican Journal of Transplantation, 2013
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopeniaJournal of Applied Physiology, 2003
- SarcopeniaJournal of Laboratory and Clinical Medicine, 2001
- Summary commentsThe American Journal of Clinical Nutrition, 1989